Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported EDIT revenue for 2026-06-30 was $14.7M. Net income was -$43.2M. EDIT currently screens at market cap $375.2M.
Use this EDIT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the EDIT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the EDIT SEC filings page. Lician reads the product cache first so this HTML stays unique to Editas Medicine Inc even when a live quote feed is slow.
Latest cached year on this hub. Full EDIT income, balance, and cash tables.